je.st
news
A Biotech Beatdown From The Biogen Perspective
2015-10-11 02:43:30| Biotech - Topix.net
The company has a $1.2 billion war chest which it can use to buy another company, buy its own shares, or issue a small dividend. I believe the bar is set pretty low for the company for this third quarter and can potentially be a catalyst to drive the stock up in the near future.
Tags: perspective
biotech
biogen
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||